The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine
Abstract
CD8 + cytotoxic T lymphocytes (CTLs) are critical for protection against intracellular pathogens but often have been difficult to induce by subunit vaccines in animals. DNA vaccines elicit protective CD8 + T cell responses. Malaria-naı̈ve volunteers who were vaccinated with plasmid DNA encoding a malaria protein developed antigen-specific, genetically restricted, CD8 + T cell–dependent CTLs. Responses were directed against all 10 peptides tested and were restricted by six human lymphocyte antigen (HLA) class I alleles. This first demonstration in healthy naı̈ve humans of the induction of CD8 + CTLs by DNA vaccines, including CTLs that were restricted by multiple HLA alleles in the same individual, provides a foundation for further human testing of this potentially revolutionary vaccine technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Genetic immunization is a simple method for eliciting an immune response
Tang, D.-C., DeVit, M., & Johnston, S. A. (1992) · Nature · doi:10.1038/356152a0 · Cited by 1,498
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
Donnelly, J. J., Ulmer, J. B., Shiver, J. W., & Liu, M. A. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.617 · Cited by 987
Molecular analysis of the association of HLA-B53 and resistance to severe malaria
Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E. M., Gotch, F. M., Ming Gao, X., Takiguchis, M., Greenwood, B. M., Townsend, A. R. M., et al. (1992) · Nature · doi:10.1038/360434a0 · Cited by 640
MacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., et al. (1998) · Journal of Infectious Diseases · doi:10.1086/515613 · Cited by 640
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
Sedegah, M., Hedstrom, R., Hobart, P., & Hoffman, S. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9866 · Cited by 447
Self-citationCellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A.-C., Sandström, E., & Wahren, B. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09440-3 · Cited by 400
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
Boyer, J. D., Ugen, K. E., Wang, B., Agadjanyan, M., Gilbert, L., Bagarazzi, M. L., Chattergoon, M., Frost, P., Javadian, A., Williams, W. V., et al. (1997) · Nature Medicine · doi:10.1038/nm0597-526 · Cited by 352
Cited by
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
DNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
“Some examples of this application include strategies that target the Rabies virus, Filovirus, Flavivirus, Togavirus and Bunyanvirus, as well as the bacterial disease agent anthrax and the malaria parasit”
MethodImmunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Rappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 704
Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo
Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K., Selby, M. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4635 · Cited by 606
McConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
Cationic microparticles: A potent delivery system for DNA vaccines
Singh, M., Briones, M., Ott, G., & O'Hagan, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.811 · Cited by 489
Dhodapkar, M. V., Steinman, R. M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S. M., Dunbar, P. R., Cerundolo, V., Nixon, D. F., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6909 · Cited by 468
DNA vaccines: an historical perspective and view to the future
Liu, M. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00980.x · Cited by 468
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
DNA Vaccines: Progress and Challenges
Donnelly, J. J., Wahren, B., & Liu, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.633 · Cited by 448
DNA and RNA-based vaccines: principles, progress and prospects
Leitner, W. W., Ying, H., & Restifo, N. P. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00271-6 · Cited by 402
Vaccines against intracellular infections requiring cellular immunity
Seder, R. A., & Hill, A. V. S. (2000) · Nature · doi:10.1038/35021239 · Cited by 394
Clinical Applications of DNA Vaccines: Current Progress
Ferraro, B., Morrow, M. P., Hutnick, N. A., Shin, T. H., Lucke, C. E., & Weiner, D. B. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir334 · Cited by 381
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
Roy, M. J., Wu, M. S., Barr, L. J., Fuller, J. T., Tussey, L. G., Speller, S., Culp, J., Burkholder, J. K., Swain, W. F., Dixon, R. M., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00302-9 · Cited by 360
Gene therapy: the first decade
Mountain, A. (2000) · Trends in Biotechnology · doi:10.1016/s0167-7799(99)01416-x · Cited by 334
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M. J., Chen, M., Otten, G. R., Ulmer, J. B., Donnelly, J. J., Ott, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2850 · Cited by 327
Use of CpG oligodeoxynucleotides as immune adjuvants
Klinman, D. M., Currie, D., Gursel, I., & Verthelyi, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00148.x · Cited by 306
Progress and challenges for malaria vaccines
Richie, T. L., & Saul, A. (2002) · Nature · doi:10.1038/415694a · Cited by 303
Bergman, P. J., Camps-Palau, M. A., McKnight, J. A., Leibman, N. F., Craft, D. M., Leung, C., Liao, J., Riviere, I., Sadelain, M., Hohenhaus, A. E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.027 · Cited by 298
Current Developments in Cancer Vaccines and Cellular Immunotherapy
Ribas, A., Butterfield, L. H., Glaspy, J. A., & Economou, J. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.041 · Cited by 295
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Ewer, K. J., O’Hara, G. A., Duncan, C. J. A., Collins, K. A., Sheehy, S. H., Reyes-Sandoval, A., Goodman, A. L., Edwards, N. J., Elias, S. C., Halstead, F. D., et al. (2013) · Nature Communications · doi:10.1038/ncomms3836 · Cited by 286
Polymeric Materials for Gene Delivery and DNA Vaccination
Nguyen, D. N., Green, J. J., Chan, J. M., Langer, R., & Anderson, D. G. (2009) · Advanced Materials · doi:10.1002/adma.200801478 · Cited by 273
Current status of malaria and potential for control
Phillips, R. S. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.208-226.2001 · Cited by 266
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines
Wang, C., Ge, Q., Ting, D., Nguyen, D., Shen, H.-R., Chen, J., Eisen, H. N., Heller, J., Langer, R., & Putnam, D. (2004) · Nature Materials · doi:10.1038/nmat1075 · Cited by 262
DNA vaccines: a key for inducing long-term cellular immunity
Gurunathan, S., Wu, C.-Y., Freidag, B. L., & Seder, R. A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00118-7 · Cited by 261
DNA vaccination: antigen presentation and the induction of immunity
Shedlock, D. J., & Weiner, D. B. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.6.793 · Cited by 259
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
Bogers, W. M., Oostermeijer, H., Mooij, P., Koopman, G., Verschoor, E. J., Davis, D., Ulmer, J. B., Brito, L. A., Cu, Y., Banerjee, K., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu522 · Cited by 181
“[mRNA] vaccines) have been evaluated in a variety of experimental clinical settings against cancer, malaria parasites, hepatitis B virus, and HIV type 1 [1–3].”
Background
Metadata
- Authors
- Wang, R., Doolan, D. L., Le, T. P., Hedstrom, R. C., Coonan, K. M., Charoenvit, Y., Jones, T. R., Hobart, P., Margalith, M., Ng, J., Weiss, W. R., Sedegah, M., de Taisne, C., A. Norman, J., & Hoffman, S. L.
- Venue
- Science
- Published
- 1998-10-16
- Volume
- 282
- Issue
- 5388
- Pages
- 476-480
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2132042285
- Cited by
- 833
- References
- 19
- FWCI
- 34.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.